Research Areas
- Breast Cancer Biology & Therapeutic
- Genetics & Epigenetics of Breast Cancer Disparity
- Spatial Omics & Systems Oncology
Scientific Achievements
- Race against time: Why TNBC is so aggressive in young African American.
- Integrating Social Determinants of Health with Breast Cancer database.
- CereNet: A Cerebellum-Inspired AI Model for Tumor Coordination Analysis.
- Mapping Immune Checkpoint Dynamics in Spatial Tumor Ecosystems.
- AI-Driven Integration of Clinical, Molecular, and Social Contexts.
- Recognized as one of 25 Women Who Shape the State of Alabama.
Funding
RCMI Funding:
- 5U54MD007585, NIH/NIMHD
Other funding obtained with RCMI support:
- 1UG3HG013553-01, National Human Genome Research Institute
- BCRFA
Scientific Advance
African Ancestry–Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent
Cancer Discov (2022) 12 (11): 2530–2551.
Cancer Discov (2022) 12 (11): 2530–2551.
Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell Lines Cancers 2022, 14(22), 5599; https://doi.org/10.3390/cancers14225599
The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides. Molecular & Cellular Oncology, https://doi.org/10.1080/23723556.2025.2471640
Methods and compositions for the identification of epithelial to mesenchymal breast cancer US Patent number 11624748
NIH/NIMHD #U54MD007585
